Cargando…
O056 The effect of acetazolamide and oxygen (ACZ+O2) combination therapy on loop gain and OSA severity
INTRODUCTION: One third of patients with OSA have high loop gain. Acetazolamide (ACZ) and supplemental oxygen (O2) individually reduce loop gain (via different mechanisms) and the apnoea-hypopnoea-index (AHI). The current study aimed to explore the efficacy of combining both ACZ and O2 to maximally...
Autores principales: | Landry, S, Collet, J, Thomson, L, Beatty, C, Mann, D, Wong, A, Turton, A, Sands, S, Joosten, S, Hamilton, G, Edwards, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109308/ http://dx.doi.org/10.1093/sleepadvances/zpac029.055 |
Ejemplares similares
-
O023 Impact of weight loss of OSA pathophysiology
por: Wong, A, et al.
Publicado: (2021) -
O027 The combination of mandibular advancement devices (MAD) and supplemental oxygen dramatically improves OSA severity: preliminary results from the MADOX trial
por: Edwards, B, et al.
Publicado: (2021) -
O028 Combination Pharmacological Therapy Targeting Multiple Mechanisms of Sleep Apnea
por: Sands, S, et al.
Publicado: (2022) -
O057 The Impact of Surgical Weight Loss on the Physiological Endotypes causing Obstructive Sleep Apnea
por: Beatty, C, et al.
Publicado: (2023) -
O060 Loop gain as a measure of respiratory instability in premature infants
por: Mann, D, et al.
Publicado: (2023)